English
简体中文
Total: £ 56.28
Published Date: 2026-03-16 | Pages: 107 | Tables: 106 | New Technology
The global Cornea Regeneration Stem Cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The cornea is the eye's major protective barrier and accounts for approximately two- thirds of the eye's total refractive power. It consists of three layers that have different embryonic origins: the epithelial layer develops from the surface ectoderm, whereas the stroma and the endothelium origin from neural crest cells (mesenchymal tissue). Experimental studies have shown that diverse types of stem cells are located in each layer. Corneal blindness due to compromised corneal transparency is a major cause of blindness. In the past few years, intensive research has focused on corneal stem cells as a source of regenerative cell-based therapy.
The North American market for Cornea Regeneration Stem Cell Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cornea Regeneration Stem Cell Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Cornea Regeneration Stem Cell Therapy in Preclinical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Cornea Regeneration Stem Cell Therapy include Holostem Terapie Avanzate, Aurion Biotech, Cellusion, LV Prasad Eye Institute, Harvard Stem Cell Institute (HSCI), Mass Eye and Ear, Astellas Institute for Regenerative Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report focuses on the global Cornea Regeneration Stem Cell Therapy status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Cornea Regeneration Stem Cell Therapy development in different regions.
It segments the global Cornea Regeneration Stem Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cornea Regeneration Stem Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Holostem Terapie Avanzate
Aurion Biotech
Cellusion
LV Prasad Eye Institute
Harvard Stem Cell Institute (HSCI)
Mass Eye and Ear
Astellas Institute for Regenerative Medicine
Segment by Type
Autologous
Allogeneic
Segment by Application
Preclinical
Clinical Phase 1,2
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cornea Regeneration Stem Cell Therapy Market Size Growth Rate by Type (2026-2032)
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Cornea Regeneration Stem Cell Therapy Market Share by Application (2026-2032)
1.3.2 Preclinical
1.3.3 Clinical Phase 1,2
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cornea Regeneration Stem Cell Therapy Market Size
2.2 Cornea Regeneration Stem Cell Therapy Market Size by Region
2.2.1 Cornea Regeneration Stem Cell Therapy Growth Rate by Region (2026-2032)
2.2.2 Cornea Regeneration Stem Cell Therapy Market Share by Region (2026-2032)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Cornea Regeneration Stem Cell Therapy Revenue by Players (2026 & 2032)
3.2 Cornea Regeneration Stem Cell Therapy Key Players Headquarters and Area Served
3.3 Key Players Cornea Regeneration Stem Cell Therapy Product/Solution/Service
3.4 Date of Enter into Cornea Regeneration Stem Cell Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and Application
4.1 Global Cornea Regeneration Stem Cell Therapy Market Size by Type (2026-2032)
4.2 Global Cornea Regeneration Stem Cell Therapy Market Size by Application (2026-2032)
5 North America
5.1 North America Cornea Regeneration Stem Cell Therapy Market Forecast (2026-2032)
5.2 Cornea Regeneration Stem Cell Therapy Key Players in North America
5.3 North America Cornea Regeneration Stem Cell Therapy Market Size by Type
5.4 North America Cornea Regeneration Stem Cell Therapy Market Size by Application
6 Europe
6.1 Europe Cornea Regeneration Stem Cell Therapy Market Forecast (2026-2032)
6.2 Cornea Regeneration Stem Cell Therapy Key Players in Europe
6.3 Europe Cornea Regeneration Stem Cell Therapy Market Size by Type
6.4 Europe Cornea Regeneration Stem Cell Therapy Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Forecast (2026-2032)
7.2 Cornea Regeneration Stem Cell Therapy Key Players in Asia-Pacific
7.3 Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Size by Type
7.4 Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Cornea Regeneration Stem Cell Therapy Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Cornea Regeneration Stem Cell Therapy Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Players Profiles
9.1 Holostem Terapie Avanzate
9.1.1 Holostem Terapie Avanzate Company Details
9.1.2 Holostem Terapie Avanzate Description and Business Overview
9.1.3 Holostem Terapie Avanzate Cornea Regeneration Stem Cell Therapy Introduction
9.1.4 Holostem Terapie Avanzate Revenue in Cornea Regeneration Stem Cell Therapy Business (2026 & 2032)
9.1.5 Holostem Terapie Avanzate Recent Development
9.2 Aurion Biotech
9.2.1 Aurion Biotech Company Details
9.2.2 Aurion Biotech Description and Business Overview
9.2.3 Aurion Biotech Cornea Regeneration Stem Cell Therapy Introduction
9.2.4 Aurion Biotech Revenue in Cornea Regeneration Stem Cell Therapy Business (2026 & 2032)
9.2.5 Aurion Biotech Recent Development
9.3 Cellusion
9.3.1 Cellusion Company Details
9.3.2 Cellusion Description and Business Overview
9.3.3 Cellusion Cornea Regeneration Stem Cell Therapy Introduction
9.3.4 Cellusion Revenue in Cornea Regeneration Stem Cell Therapy Business (2026 & 2032)
9.3.5 Cellusion Recent Development
9.4 LV Prasad Eye Institute
9.4.1 LV Prasad Eye Institute Company Details
9.4.2 LV Prasad Eye Institute Description and Business Overview
9.4.3 LV Prasad Eye Institute Cornea Regeneration Stem Cell Therapy Introduction
9.4.4 LV Prasad Eye Institute Revenue in Cornea Regeneration Stem Cell Therapy Business (2026 & 2032)
9.4.5 LV Prasad Eye Institute Recent Development
9.5 Harvard Stem Cell Institute (HSCI)
9.5.1 Harvard Stem Cell Institute (HSCI) Company Details
9.5.2 Harvard Stem Cell Institute (HSCI) Description and Business Overview
9.5.3 Harvard Stem Cell Institute (HSCI) Cornea Regeneration Stem Cell Therapy Introduction
9.5.4 Harvard Stem Cell Institute (HSCI) Revenue in Cornea Regeneration Stem Cell Therapy Business (2026 & 2032)
9.5.5 Harvard Stem Cell Institute (HSCI) Recent Development
9.6 Mass Eye and Ear
9.6.1 Mass Eye and Ear Company Details
9.6.2 Mass Eye and Ear Description and Business Overview
9.6.3 Mass Eye and Ear Cornea Regeneration Stem Cell Therapy Introduction
9.6.4 Mass Eye and Ear Revenue in Cornea Regeneration Stem Cell Therapy Business (2026 & 2032)
9.6.5 Mass Eye and Ear Recent Development
9.7 Astellas Institute for Regenerative Medicine
9.7.1 Astellas Institute for Regenerative Medicine Company Details
9.7.2 Astellas Institute for Regenerative Medicine Description and Business Overview
9.7.3 Astellas Institute for Regenerative Medicine Cornea Regeneration Stem Cell Therapy Introduction
9.7.4 Astellas Institute for Regenerative Medicine Revenue in Cornea Regeneration Stem Cell Therapy Business (2026 & 2032)
9.7.5 Astellas Institute for Regenerative Medicine Recent Development
10 Cornea Regeneration Stem Cell Therapy Market Dynamics
10.1 Cornea Regeneration Stem Cell Therapy Industry Trends
10.2 Cornea Regeneration Stem Cell Therapy Market Drivers
10.3 Cornea Regeneration Stem Cell Therapy Market Challenges
10.4 Cornea Regeneration Stem Cell Therapy Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
List of Tables
Table 1. Global Cornea Regeneration Stem Cell Therapy Market Size Growth Rate by Type (2026-2032) & (US$ Million)
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global Cornea Regeneration Stem Cell Therapy Market Size Growth by Application (2026-2032) & (US$ Million)
Table 5. Global Cornea Regeneration Stem Cell Therapy Market Size by Region (2026-2032) & (US$ Million)
Table 6. Global Cornea Regeneration Stem Cell Therapy Market Size by Region (2026-2032) & (US$ Million)
Table 7. Global Cornea Regeneration Stem Cell Therapy Market Share by Region (2026-2032)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global Cornea Regeneration Stem Cell Therapy Revenue by Players (2026 & 2032) & (US$ Million)
Table 11. Global Cornea Regeneration Stem Cell Therapy Market Share by Players (2026 & 2032)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players Cornea Regeneration Stem Cell Therapy Product/Solution/Service
Table 14. Date of Enter into Cornea Regeneration Stem Cell Therapy Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cornea Regeneration Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 17. Global Cornea Regeneration Stem Cell Therapy Market Size Share by Type (2026-2032)
Table 18. Global Cornea Regeneration Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 19. Global Cornea Regeneration Stem Cell Therapy Market Size Share by Application (2026-2032)
Table 20. North America Key Players Cornea Regeneration Stem Cell Therapy Revenue (2026 & 2032) & (US$ Million)
Table 21. North America Key Players Cornea Regeneration Stem Cell Therapy Market Share (2026 & 2032)
Table 22. North America Cornea Regeneration Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 23. North America Cornea Regeneration Stem Cell Therapy Market Share by Type (2026-2032)
Table 24. North America Cornea Regeneration Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 25. North America Cornea Regeneration Stem Cell Therapy Market Share by Application (2026-2032)
Table 26. Europe Key Players Cornea Regeneration Stem Cell Therapy Revenue (2026 & 2032) & (US$ Million)
Table 27. Europe Key Players Cornea Regeneration Stem Cell Therapy Market Share (2026 & 2032)
Table 28. Europe Cornea Regeneration Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 29. Europe Cornea Regeneration Stem Cell Therapy Market Share by Type (2026-2032)
Table 30. Europe Cornea Regeneration Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 31. Europe Cornea Regeneration Stem Cell Therapy Market Share by Application (2026-2032)
Table 32. Asia-Pacific Key Players Cornea Regeneration Stem Cell Therapy Revenue (2026 & 2032) & (US$ Million)
Table 33. Asia-Pacific Key Players Cornea Regeneration Stem Cell Therapy Market Share (2026 & 2032)
Table 34. Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Size by Type (2026-2032) & (US$ Million)
Table 35. Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Share by Type (2026-2032)
Table 36. Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Size by Application (2026-2032) & (US$ Million)
Table 37. Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Share by Application (2026-2032)
Table 38. Key Players in Latin America
Table 39. Key Players in Middle East & Africa
Table 40. Holostem Terapie Avanzate Company Details
Table 41. Holostem Terapie Avanzate Description and Business Overview
Table 42. Holostem Terapie Avanzate Cornea Regeneration Stem Cell Therapy Product
Table 43. Holostem Terapie Avanzate Revenue in Cornea Regeneration Stem Cell Therapy Business: 2026 & 2032
Table 44. Holostem Terapie Avanzate Recent Development
Table 45. Aurion Biotech Company Details
Table 46. Aurion Biotech Description and Business Overview
Table 47. Aurion Biotech Cornea Regeneration Stem Cell Therapy Product
Table 48. Aurion Biotech Revenue in Cornea Regeneration Stem Cell Therapy Business: 2026 & 2032
Table 49. Aurion Biotech Recent Development
Table 50. Cellusion Company Details
Table 51. Cellusion Description and Business Overview
Table 52. Cellusion Cornea Regeneration Stem Cell Therapy Product
Table 53. Cellusion Revenue in Cornea Regeneration Stem Cell Therapy Business: 2026 & 2032
Table 54. Cellusion Recent Development
Table 55. LV Prasad Eye Institute Company Details
Table 56. LV Prasad Eye Institute Description and Business Overview
Table 57. LV Prasad Eye Institute Cornea Regeneration Stem Cell Therapy Product
Table 58. LV Prasad Eye Institute Revenue in Cornea Regeneration Stem Cell Therapy Business: 2026 & 2032
Table 59. LV Prasad Eye Institute Recent Development
Table 60. Harvard Stem Cell Institute (HSCI) Company Details
Table 61. Harvard Stem Cell Institute (HSCI) Description and Business Overview
Table 62. Harvard Stem Cell Institute (HSCI) Cornea Regeneration Stem Cell Therapy Product
Table 63. Harvard Stem Cell Institute (HSCI) Revenue in Cornea Regeneration Stem Cell Therapy Business: 2026 & 2032
Table 64. Harvard Stem Cell Institute (HSCI) Recent Development
Table 65. Mass Eye and Ear Company Details
Table 66. Mass Eye and Ear Description and Business Overview
Table 67. Mass Eye and Ear Cornea Regeneration Stem Cell Therapy Product
Table 68. Mass Eye and Ear Revenue in Cornea Regeneration Stem Cell Therapy Business: 2026 & 2032
Table 69. Mass Eye and Ear Recent Development
Table 70. Astellas Institute for Regenerative Medicine Company Details
Table 71. Astellas Institute for Regenerative Medicine Description and Business Overview
Table 72. Astellas Institute for Regenerative Medicine Cornea Regeneration Stem Cell Therapy Product
Table 73. Astellas Institute for Regenerative Medicine Revenue in Cornea Regeneration Stem Cell Therapy Business: 2026 & 2032
Table 74. Astellas Institute for Regenerative Medicine Recent Development
Table 75. Cornea Regeneration Stem Cell Therapy Market Trends
Table 76. Cornea Regeneration Stem Cell Therapy Market Drivers
Table 77. Cornea Regeneration Stem Cell Therapy Market Challenges
Table 78. Cornea Regeneration Stem Cell Therapy Market Restraints
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cornea Regeneration Stem Cell Therapy Market Share by Type in 2026 & 2032
Figure 2. Autologous Features
Figure 3. Allogeneic Features
Figure 4. Global Cornea Regeneration Stem Cell Therapy Market Share by Application in 2026 & 2032
Figure 5. Preclinical Case Studies
Figure 6. Clinical Phase 1,2 Case Studies
Figure 7. Cornea Regeneration Stem Cell Therapy Report Years Considered
Figure 8. Global Cornea Regeneration Stem Cell Therapy Market Size and Growth Rate 2026-2032 (US$ Million)
Figure 9. Global Cornea Regeneration Stem Cell Therapy Market Share by Region (2026-2032)
Figure 10. Global Cornea Regeneration Stem Cell Therapy Market Size Market Share by Type (2026-2032)
Figure 11. North America Cornea Regeneration Stem Cell Therapy Market Size 2026-2032 (US$ Million)
Figure 12. Europe Cornea Regeneration Stem Cell Therapy Market Size 2026-2032 (US$ Million)
Figure 13. Asia-Pacific Cornea Regeneration Stem Cell Therapy Market Size 2026-2032 (US$ Million)
Figure 14. Cornea Regeneration Stem Cell Therapy Market Size in Latin America (2026-2032) & (US$ Million)
Figure 15. Cornea Regeneration Stem Cell Therapy Market Size in Middle East & Africa (2026-2032) & (US$ Million)
Figure 16. Bottom-up and Top-down Approaches for This Report
Figure 17. Data Triangulation
Figure 18. Key Executives Interviewed
